{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:59:09Z","timestamp":1778072349437,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00467-024-06621-0","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T05:07:41Z","timestamp":1734757661000},"page":"987-993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Favorable outcome in children with dense deposit disease with the use of long-term mycophenolate mofetil and high-dose alternate-day steroids"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1491-9950","authenticated-orcid":false,"given":"Uma Shankari","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran P.","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"6621_CR1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1681\/ASN.2007030356","volume":"18","author":"RJ Smith","year":"2007","unstructured":"Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de C\u00f3rdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, W\u00fcrzner R, Zipfel PF, Dense Deposit Disease Focus Group (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447\u20132456. https:\/\/doi.org\/10.1681\/ASN.2007030356","journal-title":"J Am Soc Nephrol"},{"key":"6621_CR2","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","volume":"48","author":"RH Smith","year":"2011","unstructured":"Smith RH, Harris CL, Pickering MC (2011) Dense deposit disease. Mol Immunol 48:1604\u20131610. https:\/\/doi.org\/10.1016\/j.molimm.2011.04.005","journal-title":"Mol Immunol"},{"key":"6621_CR3","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1136\/bmj.284.6332.1874-b","volume":"284","author":"RA Banks","year":"1982","unstructured":"Banks RA, May S, Wallington T (1982) Acute renal failure in dense deposit disease: recovery after plasmapheresis. Br Med J (Clin Res Ed) 284:1874\u20131875. https:\/\/doi.org\/10.1136\/bmj.284.6332.1874-b","journal-title":"Br Med J (Clin Res Ed)"},{"key":"6621_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000183504","volume":"40","author":"E McGinley","year":"2008","unstructured":"McGinley E, Watkins R, McLay A, Boulton-Jones JM (2008) Plasma exchange in the treatment of mesangiocapillary glomerulonephritis. Nephron 40:385\u2013390. https:\/\/doi.org\/10.1159\/000183504","journal-title":"Nephron"},{"key":"6621_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2215\/CJN.12901211","volume":"7","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D\u2019Agati VD, Canetta PA, Radhakrishnan J, Appel GB (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748\u2013756. https:\/\/doi.org\/10.2215\/CJN.12901211","journal-title":"Clin J Am Soc Nephrol"},{"key":"6621_CR6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.2215\/CJN.01360215","volume":"10","author":"MJ Oosterveld","year":"2015","unstructured":"Oosterveld MJ, Garrelfs MR, Hoppe B, Florquin S, Roelofs JJ, van den Heuvel LP, Amann K, Davin JC, Bouts AH, Schriemer PJ, Groothoff JW (2015) Eculizumab in pediatric dense deposit disease. Clin J Am Soc Nephrol 10:1773\u20131782. https:\/\/doi.org\/10.2215\/CJN.01360215","journal-title":"Clin J Am Soc Nephrol"},{"key":"6621_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"6621_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00467-020-04736-8","volume":"36","author":"P Khandelwal","year":"2021","unstructured":"Khandelwal P, Bhardwaj S, Singh G et al (2021) Therapy and outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis. Pediatr Nephrol 36:591\u2013600. https:\/\/doi.org\/10.1007\/s00467-020-04736-8","journal-title":"Pediatr Nephrol"},{"key":"6621_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2215\/CJN.15241219","volume":"15","author":"F Caravaca-Font\u00e1n","year":"2020","unstructured":"Caravaca-Font\u00e1n F, D\u00edaz-Encarnaci\u00f3n MM, Lucientes L et al (2020) Mycophenolate mofetil in C3 glomerulopathy and pathogenic drivers of the disease. Clin J Am Soc Nephrol 15:1287\u20131298. https:\/\/doi.org\/10.2215\/CJN.15241219","journal-title":"Clin J Am Soc Nephrol"},{"key":"6621_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/sj.sc.3101512","volume":"41","author":"B Glomsda","year":"2003","unstructured":"Glomsda B, Blaheta R, Hailer N (2003) Inhibition of monocyte\/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil. Spinal Cord 41:610\u2013619. https:\/\/doi.org\/10.1038\/sj.sc.3101512","journal-title":"Spinal Cord"},{"key":"6621_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/CJN.11740720","volume":"15","author":"Y Peleg","year":"2020","unstructured":"Peleg Y, Appel GB (2020) Mycophenolate mofetil treatment of C3 glomerulopathy. Clin J Am Soc Nephrol 15:1234\u20131236. https:\/\/doi.org\/10.2215\/CJN.11740720","journal-title":"Clin J Am Soc Nephrol"},{"key":"6621_CR12","first-page":"117","volume":"13","author":"PT McEnery","year":"1980","unstructured":"McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy. Clin Nephrol 13:117\u2013124","journal-title":"Clin Nephrol"},{"key":"6621_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/s0272-6386(88)80009-x","volume":"12","author":"PT McEnery","year":"1988","unstructured":"McEnery PT, McAdams AJ (1988) Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children. Am J Kidney Dis 12:138\u2013146. https:\/\/doi.org\/10.1016\/s0272-6386(88)80009-x","journal-title":"Am J Kidney Dis"},{"key":"6621_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMc1111953","volume":"366","author":"M Vivarelli","year":"2012","unstructured":"Vivarelli M, Pasini A, Emma F (2012) Eculizumab for the treatment of dense-deposit disease. N Engl J Med 366:1163\u20131165. https:\/\/doi.org\/10.1056\/NEJMc1111953","journal-title":"N Engl J Med"},{"key":"6621_CR15","doi-asserted-by":"publisher","first-page":"201568","DOI":"10.1155\/2014\/201568","volume":"2014","author":"A Berthe-Aucejo","year":"2014","unstructured":"Berthe-Aucejo A, Sacqu\u00e9p\u00e9e M, Fila M, Peuchmaur M, Perrier-Cornet E, Fr\u00e9meaux-Bacchi V, Desch\u00eanes G (2014) Blockade of alternative complement pathway in dense deposit disease. Case Rep Nephrol 2014:201568. https:\/\/doi.org\/10.1155\/2014\/201568","journal-title":"Case Rep Nephrol"},{"key":"6621_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/CNCS110309","volume":"8","author":"K Kasahara","year":"2020","unstructured":"Kasahara K, Gotoh Y, Majima H, Takeda A, Mizuno M (2020) Eculizumab for pediatric dense deposit disease: a case report and literature review. Clin Nephrol Case Stud 8:96\u2013102. https:\/\/doi.org\/10.5414\/CNCS110309","journal-title":"Clin Nephrol Case Stud"},{"key":"6621_CR17","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00467-020-04600-9","volume":"35","author":"C Duineveld","year":"2020","unstructured":"Duineveld C, Steenbergen EJ, Bomback AS, van de Kar NCAJ, Wetzels JFM (2020) Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury? Pediatr Nephrol 35:1791\u20131795. https:\/\/doi.org\/10.1007\/s00467-020-04600-9","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06621-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T13:49:33Z","timestamp":1741268973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06621-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6621"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06621-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}